AliveCor, a Mountain View, CA-based AI-based personal ECG technology and provider of enterprise cardiology solutions, raised $65m in Series E financing.
The round was led by existing investors OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures and Bold Capital Partners.
The company intends to use the funds to accelerate growth of its remote cardiology platform both domestically and around the world.
Led by Priya Abani, CEO, AliveCor provides the FDA-cleared KardiaMobile device, a clinically validated personal ECG solution that provides instant detection of atrial fibrillation, bradycardia, tachycardia, and normal heart rhythm in an ECG. Kardia aids patients and clinicians in the early detection of atrial fibrillation, the most common arrhythmia and one associated with a highly-elevated risk of stroke.
AliveCor’s enterprise platform allows third party providers to manage their patients and customers’ heart conditions using tools that provide easy front-end and back-end integration to AliveCor technologies.
To date, the company’s products have served more than one million customers around the world, and recorded more than 85 million ECGs.